| Invasive pulmonary aspergillosis in the COVID‐19 era: An expected new entity M Machado, M Valerio, A Álvarez‐Uría, M Olmedo, C Veintimilla, ... Mycoses 64 (2), 132-143, 2021 | 195 | 2021 |
| Multicenter evaluation of the Panbio™ COVID-19 rapid antigen-detection test for the diagnosis of SARS-CoV-2 infection P Merino, J Guinea, I Muñoz-Gallego, P González-Donapetry, JC Galán, ... Clinical Microbiology and Infection 27 (5), 758-761, 2021 | 93 | 2021 |
| Cefepime vs Other Antibacterial Agents for the Treatment of Enterobacter Species Bacteremia MJ Siedner, A Galar, BB Guzmán-Suarez, DW Kubiak, N Baghdady, ... Clinical infectious diseases 58 (11), 1554-1563, 2014 | 92 | 2014 |
| Methicillin-resistant Staphylococcus aureus prosthetic valve endocarditis: pathophysiology, epidemiology, clinical presentation, diagnosis, and management A Galar, AA Weil, DM Dudzinski, P Muñoz, MJ Siedner Clinical microbiology reviews 32 (2), 10.1128/cmr. 00041-18, 2019 | 85 | 2019 |
| Clinical and economic evaluation of the impact of rapid microbiological diagnostic testing A Galar, J Leiva, M Espinosa, F Guillén-Grima, S Hernáez, JR Yuste Journal of Infection 65 (4), 302-309, 2012 | 64 | 2012 |
| Live attenuated varicella-zoster vaccine in hematopoietic stem cell transplantation recipients NC Issa, FM Marty, H Leblebjian, A Galar, MM Shea, JH Antin, RJ Soiffer, ... Biology of Blood and Marrow Transplantation 20 (2), 285-287, 2014 | 60 | 2014 |
| Clinical and economic impact of rapid reporting of bacterial identification and antimicrobial susceptibility results of the most frequently processed specimen types A Galar, JR Yuste, M Espinosa, F Guillen-Grima, S Hernaez-Crespo, ... European journal of clinical microbiology & infectious diseases 31, 2445-2452, 2012 | 46 | 2012 |
| Pneumocystis jiroveci pneumonia (PCP) in patients receiving neoadjuvant and adjuvant anthracycline-based chemotherapy for breast cancer: incidence and risk … AG Waks, SM Tolaney, A Galar, A Arnaout, JB Porter, FM Marty, EP Winer, ... Breast cancer research and treatment 154, 359-367, 2015 | 41 | 2015 |
| A multicentre analysis of Nocardia pneumonia in Spain: 2010–2016 M Ercibengoa, J Càmara, F Tubau, D García-Somoza, A Galar, ... International Journal of Infectious Diseases 90, 161-166, 2020 | 38 | 2020 |
| Current use of daptomycin and systematic therapeutic drug monitoring: Clinical experience in a tertiary care institution A Galar, P Muñoz, M Valerio, E Cercenado, X García-González, A Burillo, ... International journal of antimicrobial agents 53 (1), 40-48, 2019 | 38 | 2019 |
| Role of dietary polyphenols and inflammatory processes on disease progression mediated by the gut microbiota JA Martínez, U Etxeberría, A Galar, FI Milagro Rejuvenation Research 16 (5), 435-437, 2013 | 36 | 2013 |
| Laboratory-Based Prospective Surveillance for Community Outbreaks of Shigella spp. in Argentina MR Viñas, E Tuduri, A Galar, K Yih, M Pichel, J Stelling, SP Brengi, ... PLoS Neglected Tropical Diseases 7 (12), e2521, 2013 | 34 | 2013 |
| Parvovirus B19 acute infection and a reactivation of cytomegalovirus and herpesvirus 6 in a chronic myeloid leukemia patient during treatment with dasatinib (BMS-354825) R García-Muñoz, A Galar, C Moreno, P Rodríguez-Otero, ... Leukemia & lymphoma 48 (12), 2461-2464, 2007 | 32 | 2007 |
| Therapeutic drug monitoring of antifungal drugs: another tool to improve patient outcome? A Vena, P Muñoz, M Mateos, J Guinea, A Galar, F Pea, A Alvarez-Uria, ... Infectious Diseases and Therapy 9, 137-149, 2020 | 31 | 2020 |
| Systematic therapeutic drug monitoring for linezolid: variability and clinical impact A Galar, M Valerio, P Muñoz, L Alcalá, X García-González, A Burillo, ... Antimicrobial Agents and Chemotherapy 61 (10), 10.1128/aac. 00687-17, 2017 | 24 | 2017 |
| Short-term risk of liver and renal injury in hospitalized patients using micafungin: a multicentre cohort study S Schneeweiss, PL Carver, K Datta, A Galar, MD Johnson, MG Johnson, ... Journal of Antimicrobial Chemotherapy 71 (10), 2938-2944, 2016 | 24 | 2016 |
| The first 100 cases of COVID-19 in a Hospital in Madrid with a 2-month follow-up P Munoz, A Galar, P Catalan, M Valerio, T Aldamiz-Echevarria, C Colliga, ... Revista Espanola de Quimioterapia 33 (5), 369, 2020 | 22 | 2020 |
| Valganciclovir—ganciclovir use and systematic therapeutic drug monitoring. An invitation to antiviral stewardship A Galar, M Valerio, P Catalán, X García-González, A Burillo, ... Antibiotics 10 (1), 77, 2021 | 19 | 2021 |
| A retrospective cohort of invasive fusariosis in the era of antimould prophylaxis A Fernández-Cruz, MA Semiglia, J Guinea, MDC Martínez-Jiménez, ... Medical mycology 58 (3), 300-309, 2020 | 18 | 2020 |
| Use of saliva swab for detection of influenza virus in patients admitted to an emergency department A Galar, P Catalán, L Vesperinas, I Miguens, I Muñoz, A García-Espona, ... Microbiology Spectrum 9 (1), 10.1128/spectrum. 00336-21, 2021 | 16 | 2021 |
